Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Cancer02:18

Cancer

56.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

12.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.

Scientific reports·2021
Same author

Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.

Scientific reports·2021
Same author

Job satisfaction of public and private primary care physicians in Malaysia: analysis of findings from QUALICO-PC.

Human resources for health·2019
Same author

Agents' beliefs and economic regimes polarization in interacting markets.

Chaos (Woodbury, N.Y.)·2018
Same author

Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Real and financial market interactions in a multiplier-accelerator model: Nonlinear dynamics, multistability and stylized facts.

Chaos (Woodbury, N.Y.)·2017

Related Experiment Video

Updated: Apr 16, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

432

Correction to Lancet Oncol 2015; 16: 133

F Cavalli, R Atun

    The Lancet. Oncology
    |March 11, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Permanent Window for Investigating Cancer Metastasis to the Lung
    07:06

    A Permanent Window for Investigating Cancer Metastasis to the Lung

    Published on: July 1, 2021

    5.8K
    Learning Modern Laryngeal Surgery in a Dissection Laboratory
    07:30

    Learning Modern Laryngeal Surgery in a Dissection Laboratory

    Published on: March 18, 2020

    8.9K

    Related Experiment Videos

    Last Updated: Apr 16, 2026

    Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
    05:30

    Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

    Published on: October 31, 2025

    432
    A Permanent Window for Investigating Cancer Metastasis to the Lung
    07:06

    A Permanent Window for Investigating Cancer Metastasis to the Lung

    Published on: July 1, 2021

    5.8K
    Learning Modern Laryngeal Surgery in a Dissection Laboratory
    07:30

    Learning Modern Laryngeal Surgery in a Dissection Laboratory

    Published on: March 18, 2020

    8.9K